Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Insights, Global Outlook and Forecast 2022-2028
Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Insights, Global Outlook and Forecast 2022-2028
The Global Gamma aminobutyric Acid (GABA) Receptor Agonist Market investigation report contains Types, Application & all logical and factual briefs about market Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like Sanofi, Mylan N.V., Teva Pharmaceutical Industries, Novartis, Aytu BioScience, Dr. Reddy’s Laboratories, Endo Pharmaceuticals, Lupin, Johnson & Johnson Services, Lannett, Sun Pharmaceutical Industries, Cipla, Aurobindo Pharma, Zydus Cadila
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Gamma-aminobutyric acid (GABA) receptor agonist drugs are a type of sedative drug that mimics the activity of the neurotransmitter receptors known as gamma-aminobutyric acid (GABA) receptors found in the mammalian brain. They are used to treat a variety of CNS disorders.
The latest research study released by Market IntelliX evaluates market size and forecasts of Gamma-aminobutyric Acid (GABA) Receptor Agonist in Global, including the following market information:
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gamma-aminobutyric Acid (GABA) Receptor Agonist market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gamma-aminobutyric Acid (GABA) Receptor Agonist include Sanofi, Mylan N.V., Teva Pharmaceutical Industries, Novartis, Aytu BioScience, Dr. Reddy’s Laboratories, Endo Pharmaceuticals, Lupin and Johnson & Johnson Services, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Gamma-aminobutyric Acid (GABA) Receptor Agonist companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Segment Percentages, by Type, 2021 (%)
Oral
Parenteral
Intrathecal
Others
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Others
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gamma-aminobutyric Acid (GABA) Receptor Agonist revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gamma-aminobutyric Acid (GABA) Receptor Agonist revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Sanofi
Mylan N.V.
Teva Pharmaceutical Industries
Novartis
Aytu BioScience
Dr. Reddy’s Laboratories
Endo Pharmaceuticals
Lupin
Johnson & Johnson Services
Lannett
Sun Pharmaceutical Industries
Cipla
Aurobindo Pharma
Zydus Cadila
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Overall Market Size
2.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size: 2021 VS 2028
2.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Players in Global Market
3.2 Top Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies Ranked by Revenue
3.3 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Companies
3.4 Top 3 and Top 5 Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Players in Global Market
3.6.1 List of Global Tier 1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies
3.6.2 List of Global Tier 2 and Tier 3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Markets, 2021 & 2028
4.1.2 Oral
4.1.3 Parenteral
4.1.4 Intrathecal
4.1.5 Others
4.2 By Type - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue & Forecasts
4.2.1 By Type - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2022
4.2.2 By Type - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2023-2028
4.2.3 By Type - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Others
5.2 By Application - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue & Forecasts
5.2.1 By Application - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2022
5.2.2 By Application - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2023-2028
5.2.3 By Application - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2021 & 2028
6.2 By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue & Forecasts
6.2.1 By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2022
6.2.2 By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2023-2028
6.2.3 By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2028
6.3.2 US Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.3.3 Canada Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.3.4 Mexico Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2028
6.4.2 Germany Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.4.3 France Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.4.4 U.K. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.4.5 Italy Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.4.6 Russia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.4.7 Nordic Countries Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.4.8 Benelux Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2028
6.5.2 China Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.5.3 Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.5.4 South Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.5.5 Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.5.6 India Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2028
6.6.2 Brazil Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.6.3 Argentina Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2028
6.7.2 Turkey Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.7.3 Israel Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.7.4 Saudi Arabia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
6.7.5 UAE Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028
7 Players Profiles
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings
7.1.4 Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)
7.1.5 Sanofi Key News
7.2 Mylan N.V.
7.2.1 Mylan N.V. Corporate Summary
7.2.2 Mylan N.V. Business Overview
7.2.3 Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings
7.2.4 Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)
7.2.5 Mylan N.V. Key News
7.3 Teva Pharmaceutical Industries
7.3.1 Teva Pharmaceutical Industries Corporate Summary
7.3.2 Teva Pharmaceutical Industries Business Overview
7.3.3 Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)
7.3.5 Teva Pharmaceutical Industries Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings
7.4.4 Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)
7.4.5 Novartis Key News
7.5 Aytu BioScience
7.5.1 Aytu BioScience Corporate Summary
7.5.2 Aytu BioScience Business Overview
7.5.3 Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings
7.5.4 Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)
7.5.5 Aytu BioScience Key News
7.6 Dr. Reddy’s Laboratories
7.6.1 Dr. Reddy’s Laboratories Corporate Summary
7.6.2 Dr. Reddy’s Laboratories Business Overview
7.6.3 Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings
7.6.4 Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)
7.6.5 Dr. Reddy’s Laboratories Key News
7.7 Endo Pharmaceuticals
7.7.1 Endo Pharmaceuticals Corporate Summary
7.7.2 Endo Pharmaceuticals Business Overview
7.7.3 Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings
7.7.4 Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)
7.7.5 Endo Pharmaceuticals Key News
7.8 Lupin
7.8.1 Lupin Corporate Summary
7.8.2 Lupin Business Overview
7.8.3 Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings
7.8.4 Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)
7.8.5 Lupin Key News
7.9 Johnson & Johnson Services
7.9.1 Johnson & Johnson Services Corporate Summary
7.9.2 Johnson & Johnson Services Business Overview
7.9.3 Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings
7.9.4 Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)
7.9.5 Johnson & Johnson Services Key News
7.10 Lannett
7.10.1 Lannett Corporate Summary
7.10.2 Lannett Business Overview
7.10.3 Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings
7.10.4 Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)
7.10.5 Lannett Key News
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Corporate Summary
7.11.2 Sun Pharmaceutical Industries Business Overview
7.11.3 Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings
7.11.4 Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)
7.11.5 Sun Pharmaceutical Industries Key News
7.12 Cipla
7.12.1 Cipla Corporate Summary
7.12.2 Cipla Business Overview
7.12.3 Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings
7.12.4 Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)
7.12.5 Cipla Key News
7.13 Aurobindo Pharma
7.13.1 Aurobindo Pharma Corporate Summary
7.13.2 Aurobindo Pharma Business Overview
7.13.3 Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings
7.13.4 Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)
7.13.5 Aurobindo Pharma Key News
7.14 Zydus Cadila
7.14.1 Zydus Cadila Corporate Summary
7.14.2 Zydus Cadila Business Overview
7.14.3 Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings
7.14.4 Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)
7.14.5 Zydus Cadila Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunities & Trends in Global Market
Table 2. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Drivers in Global Market
Table 3. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Restraints in Global Market
Table 4. Key Players of Gamma-aminobutyric Acid (GABA) Receptor Agonist in Global Market
Table 5. Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Type
Table 9. List of Global Tier 1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings
Table 32. Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)
Table 33. Mylan N.V. Corporate Summary
Table 34. Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings
Table 35. Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)
Table 36. Teva Pharmaceutical Industries Corporate Summary
Table 37. Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings
Table 38. Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings
Table 41. Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)
Table 42. Aytu BioScience Corporate Summary
Table 43. Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings
Table 44. Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)
Table 45. Dr. Reddy’s Laboratories Corporate Summary
Table 46. Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings
Table 47. Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)
Table 48. Endo Pharmaceuticals Corporate Summary
Table 49. Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings
Table 50. Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)
Table 51. Lupin Corporate Summary
Table 52. Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings
Table 53. Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)
Table 54. Johnson & Johnson Services Corporate Summary
Table 55. Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings
Table 56. Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)
Table 57. Lannett Corporate Summary
Table 58. Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings
Table 59. Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)
Table 60. Sun Pharmaceutical Industries Corporate Summary
Table 61. Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings
Table 62. Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)
Table 63. Cipla Corporate Summary
Table 64. Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings
Table 65. Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)
Table 66. Aurobindo Pharma Corporate Summary
Table 67. Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings
Table 68. Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)
Table 69. Zydus Cadila Corporate Summary
Table 70. Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings
Table 71. Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Gamma-aminobutyric Acid (GABA) Receptor Agonist Segment by Type in 2021
Figure 2. Gamma-aminobutyric Acid (GABA) Receptor Agonist Segment by Application in 2021
Figure 3. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in 2021
Figure 8. By Type - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028
Figure 12. US Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028
Figure 16. Germany Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 17. France Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028
Figure 24. China Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 28. India Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028
Figure 30. Brazil Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028
Figure 33. Turkey Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Research Methodology:
Gamma aminobutyric Acid (GABA) Receptor Agonist Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|